rhodioloside has been researched along with dinoprostone in 3 studies
Studies (rhodioloside) | Trials (rhodioloside) | Recent Studies (post-2010) (rhodioloside) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
---|---|---|---|---|---|
621 | 2 | 519 | 29,105 | 1,346 | 6,357 |
Protein | Taxonomy | rhodioloside (IC50) | dinoprostone (IC50) |
---|---|---|---|
Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abad Martínez, MJ; Bermejo Benito, P; Díaz Lanza, AM; Fernández Matellano, L; Recuero Carretero, C; Silván Sen, AM; Villaescusa Castillo, L | 1 |
Guan, S; Huang, G; Li, G; Liu, J; Lu, J; Song, B; Wang, Z; Xiong, Y; Xu, L | 1 |
Chen, Y; Feng, Z; Jin, H; Lou, Y; Tang, Q; Tian, N; Wang, C; Wang, Q; Wu, Y; Xu, H; Xu, J; Zhang, X; Zhou, Y | 1 |
3 other study(ies) available for rhodioloside and dinoprostone
Article | Year |
---|---|
Lignan and phenylpropanoid glycosides from Phillyrea latifolia and their in vitro anti-inflammatory activity.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Blood Platelets; Cells, Cultured; Cinnamates; Dinoprostone; Drug Interactions; Eicosanoids; Female; Glucosides; Glycosides; Humans; Ionophores; Leukotriene C4; Macrophages, Peritoneal; Magnoliopsida; Male; Mice; Phenols; Phenylpropionates; Plants, Medicinal; Thromboxane B2 | 2001 |
Inhibitory effects of salidroside on nitric oxide and prostaglandin E₂ production in lipopolysaccharide-stimulated RAW 264.7 macrophages.
Topics: Animals; Anti-Inflammatory Agents; Calcium; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Glucosides; Inflammation; Inflammation Mediators; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Phenols; Phytotherapy; Plant Extracts; Rhodiola; Signal Transduction | 2013 |
Endoplasmic Reticulum Stress and NF-[Formula: see text]B Pathway in Salidroside Mediated Neuroprotection: Potential of Salidroside in Neurodegenerative Diseases.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Endoplasmic Reticulum Stress; Glucosides; Inflammation Mediators; Mice; Microglia; Neurodegenerative Diseases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Phenols; Phytotherapy; RNA, Messenger; Signal Transduction | 2017 |